Journal of Cancer Research and Clinical Oncology

, Volume 126, Issue 5, pp 271–279

Bone morphogenetic protein 2 (BMP-2) induces sequential changes of Id gene expression in the breast cancer cell line MCF-7

Authors

  • Joachim H. Clement
    • Department of Internal Medicine II, Friedrich Schiller University Jena, Erlanger Allee 101, D-07740 Jena e-mail: clement@polkim.med.uni-jena.de Tel.: +49-3641-939-214 Fax: +49-3641-939-542
  • Nannette Marr
    • Department of Cell and Molecular Biology, Hans-Knöll-Institut für Naturstoff-Forschung, Beutenbergstrasse 11, D-07745 Jena
  • Anke Meissner
    • Department of Internal Medicine II, Friedrich Schiller University Jena, Erlanger Allee 101, D-07740 Jena e-mail: clement@polkim.med.uni-jena.de Tel.: +49-3641-939-214 Fax: +49-3641-939-542
  • Manuela Schwalbe
    • Department of Internal Medicine II, Friedrich Schiller University Jena, Erlanger Allee 101, D-07740 Jena e-mail: clement@polkim.med.uni-jena.de Tel.: +49-3641-939-214 Fax: +49-3641-939-542
  • Walter Sebald
    • Department of Physiological Chemistry II, Theodor-Boveri-Institute for Biosciences, University of Würzburg, Am Hubland, D-97074 Würzburg, Germany
  • Kay-Oliver Kliche
    • Department of Internal Medicine II, Friedrich Schiller University Jena, Erlanger Allee 101, D-07740 Jena e-mail: clement@polkim.med.uni-jena.de Tel.: +49-3641-939-214 Fax: +49-3641-939-542
  • Klaus Höffken
    • Department of Internal Medicine II, Friedrich Schiller University Jena, Erlanger Allee 101, D-07740 Jena e-mail: clement@polkim.med.uni-jena.de Tel.: +49-3641-939-214 Fax: +49-3641-939-542
  • Stefan Wölfl
    • Department of Cell and Molecular Biology, Hans-Knöll-Institut für Naturstoff-Forschung, Beutenbergstrasse 11, D-07745 Jena
ORIGINAL PAPER

DOI: 10.1007/s004320050342

Cite this article as:
Clement, J., Marr, N., Meissner, A. et al. J Cancer Res Clin Oncol (2000) 126: 271. doi:10.1007/s004320050342

Abstract

 Bone morphogenetic proteins (BMPs) are involved in the development of various organs including the mammary gland. They are well-regulated and act in a time-, concentration- and cell-type-specific manner. We found that BMP-2 is expressed in primary breast tumor tissue samples and in breast cancer cell lines. Hybridization of labeled cDNA, obtained from the breast cancer cell line MCF-7, against the Atlas human cDNA expression array revealed differential gene expression depending on BMP-2 treatment. The most prominent changes were observed for the helix-loop-helix proteins Id-1, Id-2 and Id-3. Id-1 expression had increased severalfold after 4 h and was even higher after 24 h. Id-2 and Id-3 were more strongly induced after 4 h and showed no further significant change after 24 h. Analysis of cell-cycle distribution revealed a marked increase of the sub-G1 phase after 48 h in serum-deprived cells. In the presence of BMP-2 no change was observed over 48 h indicating that BMP-2 does not induce apoptosis. In addition, expression of caspase-3 was reduced in BMP-2-treated cells after 24 h. In summary, our results clearly indicate that BMP-2 is a susceptibility factor keeping the cells ready for the integration of various other signals for cell progression.

Key words Tumor biologyBone morphogenetic protein 2Id proteinsExpression arrayBreast cancer
Download to read the full article text

Copyright information

© Springer-Verlag Berlin Heidelberg 2000